Fitzpatrick Mark J. 4
4 · CHIASMA, INC · Filed Feb 26, 2018
Insider Transaction Report
Form 4
CHIASMA, INCCHMA
Fitzpatrick Mark J.
CFO, Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-23+67,967→ 67,967 totalExercise: $1.52Exp: 2028-02-23→ Common Stock (67,967 underlying) - Award
Stock Option (Right to Buy)
2018-02-23+194,183→ 194,183 totalExercise: $1.52Exp: 2028-02-23→ Common Stock (194,183 underlying)
Footnotes (2)
- [F1]The shares of Common Stock underlying the option will vest in quarterly installments over 4 years from the date of grant.
- [F2]The shares of Common Stock underlying the option will vest as follows: 40% of such award will be earned upon FDA acceptance of a new drug application (NDA) for Mycapssa, of which amount 50% will be immediately vested and 50% will vest upon the one year anniversary of such acceptance; 60% of such award will be earned upon FDA approval of such NDA, of which amount 50% will be immediately vested and 50% will vest upon the one year anniversary of such approval.